Big Gain For Intensity Therapeutics Inc.
Fri, Dec 08, 2023 at 07:37 PM
Intensity Therapeutics Inc. (INTS:NASDAQ) soared at $6.88, representing a gain of 63.8%. On Fri, Dec 08, 2023, INTS:NASDAQ hit a New 2-Week High of $6.88. The stock appeared on our News Catalysts scanner on Fri, Dec 08, 2023 at 12:15 PM in the 'BIOTECH' category. From Mon, Nov 27, 2023, the stock recorded 77.78% Up Days and 50.00% Green Days
The stock spiked on Fri, Dec 08, 2023 at $11.44 with a volume of 31M+.
About Intensity Therapeutics Inc. (INTS:NASDAQ)
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 400%
- MBIA Inc. (MBI:NYSE), 81.84%
- Intensity Therapeutics Inc. (INTS:NASDAQ), 63.81%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 56.25%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 45.48%
- Assure Holdings Corp. (IONM:NASDAQ), 34.7%
- Statera Biopharma Inc. (STAB:NASDAQ), 33.33%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 32.54%
- Azitra Inc (AZTR:NYSEMKT), 28.57%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 27.64%